20
Participants
Start Date
August 28, 2024
Primary Completion Date
September 1, 2027
Study Completion Date
December 31, 2027
Irinotecan liposome Capecitabine
"Irinotecan liposome: intravenous infusion, day 1, every 2 weeks Capecitabine: oral, twice daily (bid), days 1 to 7, take for one week and then have a one-week interval.~Each 2-week period is considered a treatment cycle, with an expected treatment of 6 cycles. Subsequent maintenance treatment will be determined by the investigator's protocol until disease progression or intolerable toxicity occurs."
RECRUITING
Cancer Hospital Chinese Academy of Medical Science, Shenzhen Center, Shenzhen
Junjie Hang
OTHER